Cite
HARVARD Citation
Jacot, W. et al. (2015). Targeting triple-negative breast cancer and high-grade ovarian carcinoma: refining BRCAness beyond BRCA1/2 mutations?. Future oncology. pp. 557-559. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jacot, W. et al. (2015). Targeting triple-negative breast cancer and high-grade ovarian carcinoma: refining BRCAness beyond BRCA1/2 mutations?. Future oncology. pp. 557-559. [Online].